Lung Cancer Clinical Trial Call to Action

Campaign Aims to Match Lung Cancer Patients with Clinical Trials

(August 26, 2010)

In our continued fight against lung cancer, the American Lung Association is joining the Lung Cancer Clinical Trial Call to Action campaign as a way for lung cancer patients to take charge of their diagnosis and learn about new clinical trials.

Resources available through the Lung Cancer Clinical Trial Call to Action campaign provide personalized education to quickly identify trial options that match each patient’s specific diagnosis, stage, and treatment history.  The service aims to help lung cancer patients discuss with their doctor clinical trials that may be appropriate for them.

“Each time a person with lung cancer faces a treatment decision, clinical trials is an option they should know to consider,” said Susan Rappaport, Vice President of Research & Program Services for the American Lung Association. “Our goal is to help ease the burden patients and their families may experience when trying to understand and identify clinical trials available to them.”

Lung cancer is the number one cancer killer of both men and women, and there are currently 365,000 people living with the disease. “African Americans suffer from lung cancer more than any other population group in the United States. They are also woefully under enrolled in clinical trials,” said William J. Hicks, M.D, expert spokesperson for the American Lung Association report Too Many Cases, Too Many Deaths: Lung Cancer in African Americans. “This initiative is an important opportunity to increase African American’s access to the best available options for care and to ultimately eliminate this health disparity.”

Through the Lung Cancer Clinical Trial Call to Action campaign, the American Lung Association is hoping to advance patient care for individuals affected by lung cancer. Patients may access the service by calling the toll-free number (1-800-698-0931) or by visiting LungUSA to be matched with a compassionate and informed Clinical Trial Specialist who will guide them through the entire process.